A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 60
- Population
- ALL · 65 Years
- Duration
- 2023-12-20 to 2025-12-01
- Intervention
- aerobic exercise combined with blood flow restriction; aerobic exercise
- Comparator
- Control Group
- Outcomes measured
- Lower extremity muscle strength — Before training; Lower extremity muscle strength — After completing three-week training; Lower extremity muscle strength — After completing six-week training; Lower extremity muscle strength — At three weeks after completing the training; Lower extremity muscle strength — At six weeks after completing the training; Pulmonary function — Before training; Pulmonary function — After completing three-week training; Pulmonary function — After completing six-week training; Pulmonary function — At three weeks after completing the training; Pulmonary function — At six weeks after completing the training; Timed up and go test — Before training; Timed up and go test — After completing three-week training; Timed up and go test — After completing six-week training; Timed up and go test — At three weeks after completing the training; Timed up and go test — At six weeks after completing the training; 2 minutes step test — Before training; 2 minutes step test — After completing three-week training; 2 minutes step test — After completing six-week training; 2 minutes step test — At three weeks after completing the training; 2 minutes step test — At six weeks after completing the training
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.